Main Article Content
Objective: The aim of this study was to compare the serum paraoxonase (PON 1) levels between patients with fibromyalgia syndrome (FMS) and healthy control subjects, and to investigate the possible effect of balneotherapy (BT) on PON 1 enzyme activity in FMS patients.
Methods: The study included 45 female patients with FMS, and 35 healthy female volunteers. To measure PON 1 enzyme activity, venous blood samples were taken twice from the FMS group, before and after BT, and once from the control group. The Visual Analogue Scale (VAS) and Fibromyalgia Impact Questionnaire (FIQ) scales were applied to the FMS patients before and after BT.
Results: There was no difference between the FMS group and healthy control group in terms of serum PON1 activity (p>0.05). The comparison of the serum PON 1 activity of the FMS group before and after BT revealed a statistically significant increase after BT (p=0.001). A statistically significant decrease was determined in the VAS and FIQ scores of the FMS group after BT compared to the pre-treatment values (p=0.002, p=0.001, respectively).
Conclusion: BT is an effective non-pharmacologic method in the treatment of FMS. There was an increase in serum PON 1 activity in patients with FMS after BT. BT may have a regulatory effect on the antioxidant system of patients with FMS.
2. Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol; 2006;2:364-72.
3. Albrecht PJ, Rice FL. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms. Rev Environ Health. 2016;31:281-94
4. Santos JM, Mendonça VA, Ribeiro VGC, Tossige-Gomes R, Fonseca SF, Prates ACN et al. Does whole body vibration exercise improve oxidative stress markers in women with fibromyalgia? Braz J Med Biol Res. 2019;8:52
5. Koca TT, Seyithanoglu M, Sagiroglu S, Berk E, Dagli H. Frequency of audiological complaints in patients with fibromyalgia syndrome and its relationship with oxidative stress. Niger J Clin Pract. 2018;21:1271-1277.
6. Bayrak A, Bayrak T, Bodur E, Kılınç K, Demirpençe E. The effect of HDL bound and free PON1 on copper-induced LDL oxidation. Chem Biol Interact 2016;257:141-46.
7. Yunoki K, Naruko T, Inaba M, Inoue T, Nakagawa M et al. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease. Atherosclerosis 2013;231:308-14.
8. Hein G, Franko S. Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia. Rheumatol 2000;41:1163-171.
9. Bender T, Bariska J, Vághy R, Gomez R, Imre Kovács. Effect of balneotherapy on the antioxidant system--a controlled pilot study. Arch Med Res. 2007;38:86-9
10. Karagülle M, Kardeş S, Karagülle O, Dişçi R, Avcı A et al. Effect of spa therapy with saline balneotherapy on oxidant/antioxidant status in patients with rheumatoid arthritis: a single-blind randomized controlled trial. Int J Biometeorol. 2017;61:169-80
11. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, et al. The American Collage of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care & Research, 2010;6:600-610
12. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728-33
13. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9-2
14. Eckerson HW, Romson J, Wyte C, La Du BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet. 1983;3:214–27
15. Bozkurt M, Caglayan M, Oktayoglu P, Em S, Batmaz I et al. Serum prolidase enzyme activity and oxidative status in patients with fibromyalgia. Redox Rep. 2014;19:148-53
16. Altindag O, Gur A, Calgan N, Soran N, Celik H et al. Paraoxonase and arylesterase activities in fibromyalgia. Redox Rep. 2007;12:134-38
17. Fioravanti A, Manica P, Bortolotti R, Cevenini G, Tenti S, Paolazzi G. Is balneotherapy effective for fibromyalgia? Results from a 6-month double-blind randomized clinical trial. Clin Rheumatol. 2018;37:2203-2212.
18. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304-316
19. Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 2006; 4: 215–27.
20. El-Banna H, Jiman-Fatani A. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC Musculoskelet Disord 2014;15:379-85
21. Batuca JR, Ames PR, Isenberg DA, Alves JD. Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108:137-46
22. Pérez-Fernández MR, Calvo-Ayuso N, Martínez-Reglero, Salgado-Barreira Á, Muiño López-Álvarez JL. Efficacy of baths with mineral-medicinal water in patients with fibromyalgia: a randomized clinical trial. Int J Biometeorol. 2019;63:1161-1170
23. Yamaoka 1, Mitsunobu F, Hanamoto K, Shibuya K, Mori S, Tanizaki Y et al. Biochemical comparison between radon effects and thermal effects on humans in radon hot spring therapy J Radiat Res. 2004;45:83 - 88
24. Grabski M, Wozakowska-Kaplon B, Kedziora J. Hydrogen sulfide water balneum effect on erythrocyte superoxide dismutase activity in patients with rheumatoid arthritis-in vitro study. Przegl Lek.2004;61:1405-1409